What are the likely causes and appropriate management of oral ulcerations in a patient receiving hemodialysis?

Mouth Sores During Hemodialysis: Causes and Management

Oral ulcerations in hemodialysis patients are primarily caused by uremic toxins, immunosuppression, xerostomia, poor oral hygiene, and medication side effects—particularly in transplant recipients on immunosuppressants like mycophenolate mofetil or cyclosporine. Management requires eliminating infections, optimizing oral hygiene, and addressing underlying systemic factors while recognizing that these patients face significantly increased infection risk and mortality, particularly with oral candidiasis 1, 2.

Primary Etiologies in Hemodialysis Patients

Uremia-Related Factors

Hemodialysis patients develop oral manifestations from endocrinological imbalances, uremic metabolic disorders, and immunological alterations 1. The accumulation of uremic toxins directly affects oral tissues, causing:

• Xerostomia (dry mouth) from reduced salivary flow, minor salivary gland fibrosis, fluid restriction, and xerostomizing medications 1
• Altered salivary composition with elevated urea, creatinine, sodium, potassium, chloride, and phosphorus 1
• Ammonia taste and breath from salivary urea conversion 1

Immunocompromised Status

Patients on hemodialysis are at substantially greater risk for infections due to their immunocompromised state 1. This creates vulnerability to:

• Oral candidiasis, which carries the highest mortality risk—associated with 37% increased all-cause mortality and 64% increased cardiovascular mortality 2
• Viral infections (herpes simplex)
• Bacterial infections from poor oral hygiene

Medication-Induced Ulceration

Immunosuppressants in transplant recipients are a critical but often overlooked cause:

• Mycophenolate mofetil can cause large, painful oral ulcers that significantly degrade quality of life 3
• Cyclosporine causes gingival enlargement that may mimic or complicate ulcerative lesions 1
• Calcium channel blockers (common antihypertensives in this population) cause gingival enlargement 1

Coagulation Abnormalities

Hemodialysis causes platelet dysfunction, combined with heparin anticoagulation during dialysis, leading to gingival bleeding and potentially traumatic ulceration 1.

Diagnostic Approach

Initial Assessment

For oral ulceration persisting >2 weeks or not responding to 1-2 weeks of treatment, proceed systematically 4:

1. Blood tests before biopsy:

   • Full blood count (rule out anemia, leukemia)
   • Coagulation studies
   • Fasting blood glucose (fungal infection risk with hyperglycemia)
   • HIV antibody and syphilis serology
   • Blood iron, folate, vitamin B12 if anemia suspected 4

2. Evaluate infection markers:

   • C-reactive protein (CRP) is critical—CRP ≤0.1 mg/dL indicates well-controlled inflammation and better treatment response 5
   • Oral candidiasis requires aggressive treatment given mortality implications 2

3. Review medication history:

   • If transplant recipient on MMF with ulcers unresponsive to antifungals/antivirals, consider stopping MMF—ulcers typically heal quickly after discontinuation 3
   • Consult nephrologist about switching cyclosporine to tacrolimus if gingival enlargement present 1

Management Algorithm

Step 1: Eliminate Active Infections

This is non-negotiable before any other intervention 1:

• Treat oral candidiasis aggressively (fluconazole with dose adjustment for renal function)
• Address viral infections (acyclovir with renal dosing)
• Eliminate plaque biofilm and dental caries
• Provide periodontal treatment to prevent peri-implant disease

Step 2: Optimize Oral Hygiene

Hemodialysis patients have significantly higher plaque and calculus indices than controls 6:

• Institute regular periodontal maintenance program
• Address xerostomia with saliva substitutes and frequent water sips (within fluid restrictions)
• Recommend proper daily oral hygiene despite poor compliance patterns 1, 7

Step 3: Address Medication Causes

If ulcers persist after infection treatment:

• Check tacrolimus/cyclosporine levels (ensure therapeutic range)
• If MMF-related, discontinue MMF after nephrologist consultation 3
• For calcium channel blocker-induced gingival enlargement, switch to alternative antihypertensive 1
• For cyclosporine-induced changes, consider switching to tacrolimus 1

Step 4: Correct Metabolic Abnormalities

• Evaluate and supplement vitamin D (deficiency affects mucosal healing and bone metabolism) 1
• Monitor PTH, 1,25(OH)D, and FGF23 levels 1
• Optimize anemia management (may require oral iron if CRP ≤0.1 mg/dL) 5

Step 5: Biopsy if Unresolved

For ulcers >2 weeks or treatment-refractory cases, biopsy is mandatory to rule out malignancy or systemic disease 4.

Critical Pitfalls to Avoid

1. Do not dismiss oral candidiasis as benign—it independently predicts cardiovascular death 2

2. Do not assume all ulcers are infection-related—medication causes (especially MMF) are frequently missed 3

3. Do not perform dental procedures without timing considerations—schedule on first day after hemodialysis when toxins are cleared, intravascular volume is optimal, and heparin metabolism is ideal 1

4. Do not use standard antibiotic dosing—adjust for renal function and avoid nephrotoxic agents (aminoglycosides, tetracyclines, nitrofurantoin) 1

5. Do not overlook bleeding risk—check coagulation before any invasive procedure; bleeding times >10-15 minutes indicate high hemorrhage risk 1

Antibiotic Prophylaxis for Procedures

Given the one-third infection rate and high endocarditis risk in this population 1:

• Standard regimen: Amoxicillin 2g orally 1 hour before procedure
• Penicillin allergy: Clindamycin 600mg orally 1 hour before procedure
• Dose adjustments based on residual kidney function in consultation with nephrologist 1

Prognosis Considerations

Oral mucosal lesions are prevalent (40% of hemodialysis patients affected) 2. The presence of oral candidiasis specifically increases mortality risk, making aggressive treatment and prevention essential for improving both quality of life and survival 2. Regular oral examination and prompt intervention directly impact morbidity and mortality outcomes in this vulnerable population.